- Home
- WASH vs PLRX Comparison
WASH vs PLRX Comparison
Compare WASH & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- PLRX
- Stock Information
- Founded
- WASH 1800
- PLRX 2015
- Country
- WASH United States
- PLRX United States
- Employees
- WASH N/A
- PLRX N/A
- Industry
- WASH Major Banks
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- WASH Finance
- PLRX Health Care
- Exchange
- WASH Nasdaq
- PLRX Nasdaq
- Market Cap
- WASH 613.2M
- PLRX 682.2M
- IPO Year
- WASH N/A
- PLRX 2020
- Fundamental
- Price
- WASH $32.47
- PLRX $10.92
- Analyst Decision
- WASH Hold
- PLRX Strong Buy
- Analyst Count
- WASH 2
- PLRX 7
- Target Price
- WASH $34.00
- PLRX $40.50
- AVG Volume (30 Days)
- WASH 183.7K
- PLRX 473.9K
- Earning Date
- WASH 01-29-2025
- PLRX 02-26-2025
- Dividend Yield
- WASH 6.87%
- PLRX N/A
- EPS Growth
- WASH N/A
- PLRX N/A
- EPS
- WASH 2.67
- PLRX N/A
- Revenue
- WASH $188,967,000.00
- PLRX N/A
- Revenue This Year
- WASH N/A
- PLRX N/A
- Revenue Next Year
- WASH $11.60
- PLRX N/A
- P/E Ratio
- WASH $12.16
- PLRX N/A
- Revenue Growth
- WASH N/A
- PLRX N/A
- 52 Week Low
- WASH $24.11
- PLRX $10.22
- 52 Week High
- WASH $40.59
- PLRX $18.92
- Technical
- Relative Strength Index (RSI)
- WASH 50.61
- PLRX 36.45
- Support Level
- WASH $31.99
- PLRX $10.68
- Resistance Level
- WASH $33.39
- PLRX $11.40
- Average True Range (ATR)
- WASH 0.94
- PLRX 0.71
- MACD
- WASH 0.37
- PLRX -0.14
- Stochastic Oscillator
- WASH 79.78
- PLRX 7.92
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.